Cognition Therapeutics, Inc. CGTX

Set alert

Price alert · CGTX

All alert types
0.71 USD +0.01 +1.63%

At close

0.77 +0.06 +8.51%

Pre-market · Nov 3, 4:00 AM ET

Bid
0.70 × 1
Ask
0.71 × 1
0.699 Day range 0.7399
0.55 52-week range 1.83
YTD
-47.44%
1 year
-60.36%
Open
0.699
Prev close
0.6982
Mkt cap
67.48M
Vol
346.58K
Avg vol
516.99K
EPS
-0.17
P/E
0.00
Div yield
0.00%
More statistics
Low
0.699
High
0.7399
Forward P/E
-0.80
Beta
1.33
Short ratio
1.07
Inst. own
24.53%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
0.47888
200-d avg
1.23
1y target
6.50

MAX chart

Chart tools
Interval

Events in this range
  • Mar 26, 2024Earnings: —; estimate -0.38; surprise —%
  • May 7, 2024Earnings: -0.27; estimate -0.23; surprise -17.39%
  • May 7, 2024Earnings: —; estimate -0.23; surprise —%
  • Aug 8, 2024Earnings: —; estimate -0.22; surprise —%
  • Aug 8, 2024Earnings: -0.18; estimate -0.22; surprise 18.18%
  • Nov 4, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 13, 2024Earnings: -0.25; estimate -0.24; surprise -4.17%
  • Nov 15, 2024Rating: Chardan Capital · Buy → Buy
  • Nov 27, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Dec 19, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Dec 19, 2024Rating: Chardan Capital · Buy → Buy
  • Dec 19, 2024Rating: B. Riley Securities · Neutral → Buy
Signals (87)
NameDateAgo
SMA: BearishSep 21, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishAug 31, 20262 months ago
MACD: Sell SignalJul 13, 20263 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 1, 20265 months ago
MACD: Buy SignalApr 27, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BearishJan 5, 202610 months ago
SMA: BearishDec 15, 202510 months ago
SMA: BullishNov 24, 202511 months ago
MACD: Sell SignalOct 27, 20251 year ago
SMA: BearishSep 15, 20251 year ago
RSI: OverboughtAug 11, 20251 year ago
SMA: BullishJul 7, 20251 year ago
SMA: BullishJun 30, 20251 year ago

Newest 20 of 87.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 6.50 +816.0% upside
Target (low)
1.50
Target (mean)
6.50
Target (high)
11.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CGTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.185-0.34 – -0.07-0.27+31.5%00.0%4
Next quarter-0.12-0.13 – -0.11-0.27+55.6%00.0%2
Current year-0.8525-1.10 – -0.62-0.86+0.9%00.0%4
Next year-0.805-1.71 – -0.31-0.8525+5.6%00.0%4

Upgrades and downgrades

The latest rating changes

CGTX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024B. Riley SecuritiesUpgradeNeutralBuy
Dec 19, 2024Chardan CapitalMaintainedBuyBuy
Dec 19, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 27, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 15, 2024Chardan CapitalMaintainedBuyBuy
Nov 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024Chardan CapitalMaintainedBuyBuy
Aug 12, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 6, 2024B. Riley SecuritiesDowngradeBuyNeutral
Aug 1, 2024HC Wainwright & Co.MaintainedBuyBuy
Jul 30, 2024Cantor FitzgeraldDowngradeOverweightNeutral
Jul 2, 2024Rodman & RenshawReiteratedBuyBuy
Jun 6, 2024Chardan CapitalInitiated—Buy
May 29, 2024HC Wainwright & Co.Initiated—Buy
Mar 28, 2024B. Riley SecuritiesReiteratedBuyBuy
Mar 27, 2024OppenheimerMaintainedOutperformOutperform
Aug 14, 2023Ladenburg ThalmannMaintainedBuyBuy
May 9, 2023OppenheimerReiterated—Outperform
Mar 24, 2023OppenheimerReiterated—Outperform
Sep 29, 2022Cantor FitzgeraldInitiated—Overweight
Apr 22, 2022Ladenburg ThalmannInitiated—Buy
Nov 3, 2021OppenheimerInitiated—Outperform